Roundup

Five things for pharma marketers to know: Wednesday, July 18, 2018

Five things for pharma marketers to know: Wednesday, July 18, 2018

By

Novartis voluntarily halts price increases; Shkreli's former company considers name change; FDA issues guidance to modernize electronic health data in trials.

Five things for pharma marketers to know: Tuesday, July 17, 2018

Five things for pharma marketers to know: Tuesday, July 17, 2018

By

J&J beats expectations on Q2 earnings; AbbVie, Mylan sign U.S. license deal for Humira; Roche's new flu drug meets endpoints.

Five things for pharma marketers to know: Monday, July 16, 2018

Five things for pharma marketers to know: Monday, July 16, 2018

MM&M Awards shortlist revealed; FDA approves first smallpox treatment; Another way Amazon could drive down healthcare costs.

Five things for pharma marketers to know: Friday, July 13, 2018

Five things for pharma marketers to know: Friday, July 13, 2018

By

Senate probe finds more contact between Novartis, Cohen; J&J ordered to pay $4.7 billion in talc lawsuit; FDA warns Arog about misleading promotional material.

Five things for pharma marketers to know: Wednesday, July 11, 2018

Five things for pharma marketers to know: Wednesday, July 11, 2018

Pfizer announces restructuring hours after about face on price hikes; Feds to slash funding for ACA "navigators"; Study finds rural states lag in combating heart disease.

Five things for pharma marketers to know: Tuesday, July 10, 2018

Five things for pharma marketers to know: Tuesday, July 10, 2018

By

CMS ends plan to make Novartis cancer treatment cheaper; Trump calls out Pfizer on Twitter for price hikes; News organizations sue to get federal opioid data.

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

Five Agency 100 things for pharma marketers to know: Monday, July 9, 2018

The most comprehensive look at the pharma and healthcare agency world from MM&M.

Five things for pharma marketers to know: Friday, July 6, 2018

Five things for pharma marketers to know: Friday, July 6, 2018

Positive Alzheimer's trial sends Biogen shares surging; A year after crisis, analysts come around to AstraZeneca stock; Ironwood cuts 40 jobs ahead of split.

Five things for pharma marketers to know: Thursday, July 5, 2018

Five things for pharma marketers to know: Thursday, July 5, 2018

Amazon integration with PillPack could happen quickly; White House names DEA chief; Purdue stops marketing opioids in Canada.

Five things for pharma marketers to know: Tuesday, July 3, 2018

Five things for pharma marketers to know: Tuesday, July 3, 2018

By

UDG Healthcare makes two acquisitions; Lundbeck names Dunsire CEO; Accuracy of DTC genetic tests questioned.

Five things for pharma marketers to know: Monday, July 2, 2018

Five things for pharma marketers to know: Monday, July 2, 2018

By

U.S. hospitals face staple drug shortage; Pfizer hikes price of 100 products; Federal judge blocks Kentucky work-requirement-for-Medicaid plan.

Five things for pharma marketers to know: Friday, June 29, 2018

Five things for pharma marketers to know: Friday, June 29, 2018

By

Fosamax appeal goes to Supreme Court; Gottlieb weighs in on Amazon-PillPack deal; Senator demands PhRMA, BIO address sexual harassment.

Five things for pharma marketers to know: Wednesday, June 27, 2018

Five things for pharma marketers to know: Wednesday, June 27, 2018

By

FDA gives priority review to new type of flu treatment; Lynparza shows positive trial data; Nurse practitioner lobby launches national campaign.

Five things for pharma marketers to know: Tuesday, June 26, 2018

Five things for pharma marketers to know: Tuesday, June 26, 2018

By

FDA approves first prescription drug derived from marijuana; Alphabet aging unit raises $1 billion; GE to spin off healthcare business.

Five things for pharma marketers to know: Monday, June 25, 2018

Five things for pharma marketers to know: Monday, June 25, 2018

By

How Atul Gawande caught Warren Buffett's eye; Positive news for Roche's Tecentriq in trial; New York State officials argue Orkambi not worth the cost.

Five things for pharma marketers to know: Friday, June 22, 2018

Five things for pharma marketers to know: Friday, June 22, 2018

By

Opioid supply levels drop; Azar criticized for attending college reunion during border crisis; CVS CEO confident about Aetna deal.

Five things for pharma marketers to know: Thursday, June 21, 2018

Five things for pharma marketers to know: Thursday, June 21, 2018

By

GoodRx in sales talks; Heron receives breakthrough therapy designation for pain treatment; Novo's diabetes pill proves effective in clinical trials.

Five things for pharma marketers to know: Wednesday, June 20, 2018

Five things for pharma marketers to know: Wednesday, June 20, 2018

By

Dr. Atul Gawande named CEO of Amazon, J.P. Morgan, Berkshire Hathaway healthcare venture; Facebook tries to curb illegal opioid sales; More sales layoffs at Purdue Pharma.

Five things for pharma marketers to know: Tuesday, June 19, 2018

Five things for pharma marketers to know: Tuesday, June 19, 2018

By

White House to roll out Affordable Care Act rule change; CVS Health teams up with Postal Service; Roche to buy rest of Foundation Medicine.

Five things for pharma marketers to know: Monday, June 18, 2018

Five things for pharma marketers to know: Monday, June 18, 2018

By

Quest Analytics buys BetterDoctor; Analyst Eric Schmidt to join Allogene Therapeutics; Two-thirds of Americans "very concerned" about cost of health insurance.

Five things for pharma marketers to know: Friday, June 16, 2018

Five things for pharma marketers to know: Friday, June 16, 2018

By

Eli Lilly CEO says changes needed in drug pricing system; Kentucky sues Walgreens over opioid epidemic; Teva faces migraine drug setback.

Five things for pharma marketers to know: Thursday, June 14, 2018

Five things for pharma marketers to know: Thursday, June 14, 2018

By

BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.

Five things for pharma marketers to know: Wednesday, June 13, 2018

Five things for pharma marketers to know: Wednesday, June 13, 2018

By

Drugmakers not dropping prices on Trump timeline; Azar backs insurance for those with preexisting conditions; Stryker denies interest in Boston Scientific takeover.

Five things for pharma marketers to know: Tuesday, June 12, 2018

Five things for pharma marketers to know: Tuesday, June 12, 2018

By

FDA puts Sage depression treatment on accelerated timeline; AstraZeneca, Lilly cease Alzheimer's treatment trial; Stryker makes offer for Boston Scientific.

Five things pharma marketers need to know: Monday, June 11, 2018

Five things pharma marketers need to know: Monday, June 11, 2018

By

Eckert returns to lead Sprout Pharmaceuticals; Sorrell denies prostitution allegation; AHIP warns about removing key Obamacare provisions.

Five things for pharma marketers to know: Friday, June 8, 2018

Five things for pharma marketers to know: Friday, June 8, 2018

By

Novo Nordisk considers cutting 3,000 jobs; Pharma companies pressured to move birth control over the counter; Gates Foundation launches a nonprofit biotech.

Five things for pharma marketers to know: Thursday, June 7, 2018

Five things for pharma marketers to know: Thursday, June 7, 2018

Bayer closes Monsanto deal after lengthy antitrust review; Bezos, Dimon, Buffett pick CEO to run healthcare venture; Novartis to avoid criminal actions over Cohen payments.

Five things for pharma marketers to know: Wednesday, June 6, 2018

Five things for pharma marketers to know: Wednesday, June 6, 2018

Athenahealth CEO steps down; Former Celgene chief executive wins New Jersey Senate primary; Big Pharma not planning campaign against Trump drug pricing plan.

Five things for pharma marketers to know: Tuesday, June 5, 2018

Five things for pharma marketers to know: Tuesday, June 5, 2018

By

Medicare Part D brand-name drug costs up even as prescriptions fall; Gottlieb could speed up approval process for competitors of first-to-market drugs; FDA approves Filphila.

Five things for pharma marketers to know: Friday, June 1, 2018

Five things for pharma marketers to know: Friday, June 1, 2018

By

Opioid prescriptions drop for fifth year in a row; AstraZeneca reprimanded by U.K. regulator; Samsung partners with Babylon to bring appointments to smartphones.